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Abstract 
This study was to investigate the antimicrobial resistance of Staphylococcus aureus isolated in 8 consecutive years in 
the First Bethune Hospital. Disk diffusion test was used to study the antimicrobial resistance. The data were analyzed 
by WHONET 5 software according to Clinical and Laboratory Standards Institute (CLSI). Most of 1469 strains of 
Staphylococcus aureus were collected from sputum 705 (18.0%), secretions 206 (14.0%), pus 177 (12.0%) during the 
past 8 years. The rates of methicillin-resistant Staphylococcus aureus (MRSA) were between 50.8  and 83.3  
during the past 8 years, respectively. In recent 8 years, the antimicrobial resistance of Staphylococcus aureus had 
increased. Monitoring the antimicrobial resistance to Staphylococcus aureus should be strengthened. The change of 
the antimicrobial resistance should be investigated in order to direct rational drug usage in the clinic and prevent 
bacterial strain of drug resistance from being transmitted. 
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1.Introduction 
Methicillin-resistant Staphylococcus aureus (MRSA) poses a major threat to public health worldwide, 
due to the rapid spread and diversification of pandemic MRSA clones with increasing virulence and 
antimicrobial resistance[1]. In Staphylococcus aureus, antimicrobial resistance has been more frequently 
found among MRSA strains than among methicillin-sensitive Staphylococcus aureus (MSSA) strains, 
which may be related to the mecA-mediated resistance. The objectives of this study were to investigate 
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the antimicrobial resistance of Staphylococcus aureus isolated in 8 consecutive years in the First Bethune 
Hospital. 
2.Materials and methods 
2.1.Bacterial isolates 
Consecutive nonduplicate nosocomial isolates of Staphylococcus aureus were collected during the 
period from 2003 to 2010 in the First Bethune Hospital. Isolates were identified at the species level using 
standard biochemical tests and microbiological methods. 
2.2.Antimicrobial susceptibility testing 
The susceptibilities of Staphylococcus aureus to 19 antimicrobial agents were determined by the disk 
diffusion method in accordance with Clinical and Laboratory Standards Institute (CLSI) guidelines. 
2.3.Detection of MRSA.  
Detection of MRSA was according to CLSI. Staphylococcus aureus ATCC 25923 and 
Staphylococcus aureus ATCC 43300 strains served as quality controls.  
3.Results 
Distribution of specimen type: during the 8-year study period, 1469 consecutive clinical isolates of 
Staphylococcus aureus were isolated. The strains were cultured from sputum 705 (48.0%), secretions 206 
(14.0%), pus 177 (12.0%), blood 100 (6.8%), urine 69 (4.7%), pleural fluid and abdominal fluid 62 
(4.2%), bile 44 (3.0%), bone marrow 38 (2.6%), others 68 (4.6%)  
The rates of MRSA were 50.8% (31/61), 58.0% (40/69), 60% (48/80), 79.8% (79/99), 83.3% 
(100/120), 80.8% (295/365), 81.3% (260/320), 80.3.% (285/355) from 2003 to 2010, respectively. 
Resistance of MRSA and MSSA is shown in table 1  
4.Discussion 
The rapid emergence and spread of drug-resistant organisms, such as Staphylococcus aureus, both in 
the healthcare setting and the community prompts great urgency in the development of and advocacy for 
prevention and treatment efforts. Staphylococcus aureus, a gram-positive bacterium, is both a commensal 
organism found as part of the normal human flora in 30 percent of the population as well as a resourceful 
human pathogen able to cause severe and devastating illness[2]. The top three specimen types in the 
present study were sputum, secretions and pus in the past 8 years in the First Bethune Hospital. It is 
emphasized that Staphylococcus aureus are mainly responsible for pneumonia and wound infection in the 
First Bethune Hospital. 
The current study showed prevalence of MRSA ranging from 50.8  to 83.3  in Staphylococcus 
aureus in the First Bethune Hospital was higher in Canada and America[3-4]. It is associated with 
different geography, breakpoints, or antimicrobial susceptibility testing. Clinical laboratories need to have 
adequate equipment and expertise to provide detection method for MRSA. 
In addition to excellent activity of vancomycin and teicoplanin, the resistance rates of MRSA for 
clindamycin, rifampin, piperacillin/tazobactam, erythromycin, tetracycline, penicillin G, ampicilin, 
cefazolin, cefuroxime sodium, cefotaxime, cefepime, ciprofloxacin, levofloxacin, gatifloxacin were 
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almost more than 50% during 8 years in the First Bethune Hospital. However, antimicrobial resistance of 
MSSA to almost antibiotics except clindamycin, erythromycin, penicillin G, and ampicilin were no more 
than 40.0 The resistance rates of MRSA to the most antibiotics are much higher than those of MSSA 
during 8 years in the First Bethune Hospital. Methicillin resistance is mediated via a chromosomally 
incorporated resistance gene, mecA, which confers altered binding of -lactams to penicillin binding 
protein 2a. The mecA gene is packaged in a cassette called the staphylococcal cassette cartridge (SCC), 
which aids in successful chromosomal incorporation[5]. 
Monitoring antibiotic use with microbiology laboratory support can promote rational drug utilization, 
cut costs and delay the emergence of resistant organisms. 
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TABLE 1  Antimicrobial resistance of STAPHYLOCOCCUS AUREUS ( ) 
ANT 
2003 (n=61) 2004 (n=69) 2005 (n=80) 2006 (n=99) 2007 (n=120) 2008 (n=3650 2009 (n=360) 2010 (n=355) 
MSSA 
(n=30) 
MRSA 
(n=31) 
MSSA 
(n=29) 
MRSA 
(n=40) 
MSSA 
(n=32) 
MRSA 
(n=48) 
MSSA 
(n=20) 
MRSA 
(n=79) 
MSSA 
(n=20) 
MRSA 
(n=100) 
MSSA 
(n=70) 
MRSA 
(n=295) 
MSSA 
(n=60) 
MRSA 
(n=260) 
MSSA 
(n=70) 
MRSA 
(n=285) 
VAN 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
TEC 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.4 
FOX     0.0 100.0 0.0 100.0 0.0 100.0 0.0 100.0 0.0 100.0 0.0 100.0 
OXA 0.0 100.0 0.0 100.0 0.0 100.0 0.0 100.0 0.0 100.0 0.0 100.0 0.0 100.0 0.0 100.0 
SXT 23.3 32.3 20.7 30.0 21.9 29.2 20.0 21.5 15.0 20.0 14.3 20.3 15.0 20.8 14.3 20.0 
CLI 33.3 71.0 37.9 72.5 40.6 90.9 50.0 86.1 50.0 92.0 52.9 93.2 56.7 92.3 52.9 93.0 
RIF 10.0 32.3 10.3 35.0 12.5 33.3 10.0 88.6 15.0 87.0 12.9 83.1 13.3 80.8 14.3 87.7 
TZP 6.7 71.0 6.9 72.5 9.8 83.3 15.0 89.9 15.0 93.0 18.6 91.5 18.3 92.3 20.0 94.7 
ERY 60.0 87.1 62.1 87.5 62.5 90.0 75.0 91.1 75.0 92.0 78.6 94.9 81.7 96.5 81.4 93.3 
TCY 30.0 67.7 31.0 77.5 31.3 87.5 30.0 91.1 40.0 93.0 38.6 94.9 38.3 95.4 40.0 94.7 
PEN 66.7 100.0 69.0 100.0 83.3 100.0 90.0 100.0 90.0 100.0 92.9 100.0 93.3 100.0 95.0 100.0 
AMP 66.7 100.0 69.0 100.0 83.3 100.0 90.0 100.0 90.0 100.0 92.9 100.0 93.3 100.0 95.0 100.0 
CZO 0.0 87.1 0.0 80.0 0.0 87.5 0.0 92.3 5.0 94.0 1.4 93.2 3.3 95.4 4.3 94.7 
CXM 3.3 90.3 3.4 87.5 6.3 93.8 5.0 93.7 5.0 95.0 5.7 96.9 8.3 95.8 8.6 95.4 
CTX 3.3 87.1 6.9 80.0 9.4 89.6 10.0 93.7 10.0 96.0 18.6 96.9 18.3 97.3 20.0 97.5 
FEP 3.3 87.1 6.9 77.5 9.4 87.5 10.0 96.2 10.0 94.0 17.1 94.6 18.3 95.8 18.6 97.2 
CIP 6.7 80.6 6.9 87.5 12.5 91.7 15.0 98.7 15.0 98.0 25.7 98.3 23.3 98.1 24.3 98.2 
LEV 6.7 71.0 6.9 77.5 9.4 91.7 10.0 94.9 10.0 94.0 18.6 96.6 16.7 96.2 18.6 97.2 
GAT 3.3 32.3 3.4 40.0 6.3 49.0 5.0 59.5 5.0 66.0 11.4 70.2 10.0 71.2 10.0 77.2 
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Note: ANT: antibiotics, VAN: vancomycin, TEC: teicoplanin, FOX: cefoxitin, OXA: oxacillin, SXT: 
trimethoprim/sulfamethoxazole, CLI: clindamycin, RIF: rifampin, TZP: piperacillin/tazobactam, ERY: erythromycin, TCY: 
tetracycline, PEN: penicillin G, AMP: ampicilin, CZO: cefazolin, CXM: cefuroxime sodium, CTX: cefotaxime, FEP: cefepime, CIP: 
ciprofloxacin, LEV: levofloxacin, GAT: gatifloxacin, MSSA: methicillin-sensitive Staphylococcus aureus, MRSA: 
methicillin-resistant Staphylococcus aureus, : no data 
 
